RESUMEN
BACKGROUND: Acid sphingomyelinase deficiency (ASMD) or Niemann-Pick disease types A, A/B, and B is a progressive, life-limiting, autosomal recessive disorder caused by sphingomyelin phosphodiesterase 1 (SMPD1) gene mutations. There is a need to increase the understanding of morbidity and mortality across children to adults diagnosed with ASMD. METHODS: This observational retrospective survey analysed medical records of patients with ASMD with retrievable data from 27 hospitals in France, diagnosed/followed up between 1st January 1990 and 31st December 2020. Eligible records were abstracted to collect demographic, medical/developmental history, and mortality data. Survival outcomes were estimated from birth until death using Kaplan-Meier survival analyses; standardised mortality ratio (SMR) was also explored. RESULTS: A total of 118 medical records of patients with ASMD (type B [n = 94], type A [n = 15], and type A/B [n = 9]) were assessed. The majority of patients were males (63.6%); the median [range] age at diagnosis was 8.0 [1.0-18.0] months (type A), 1.0 [0-3] year (type A/B), and 5.5 [0-73] years (type B). Overall, 30 patients were deceased at the study completion date; the median [range] age at death for patients with ASMD type A (n = 14) was 1 [0-3.6] year, type A/B (n = 6) was 8.5 [3.0-30.9] years, and type B (n = 10) was 57.6 [3.4-74.1] years. The median [95% confidence interval (CI)] survival age from birth in patients with ASMD type A and type A/B was 2.0 [1.8-2.7] years and 11.4 [5.5-18.5] years, respectively. Survival analysis in ASMD type B was explored using SMR [95% CI] analysis (3.5 [1.6-5.9]), which showed that age-specific deaths in the ASMD type B population were 3.5 times more frequent than those in the general French population. The causes of death were mostly severe progressive neurodegeneration (type A: 16.7%), cancer (type B: 16.7%), or unspecified (across groups: 33.3%). CONCLUSIONS: This study illustrated a substantial burden of illness with high mortality rates in patients with ASMD, including adults with ASMD type B, in France.
Asunto(s)
Esfingomielina Fosfodiesterasa , Humanos , Estudios Retrospectivos , Masculino , Francia/epidemiología , Femenino , Lactante , Esfingomielina Fosfodiesterasa/genética , Esfingomielina Fosfodiesterasa/deficiencia , Esfingomielina Fosfodiesterasa/metabolismo , Preescolar , Niño , Adulto , Adolescente , Adulto Joven , Enfermedades de Niemann-Pick/mortalidad , Persona de Mediana EdadRESUMEN
Although cholesterol is a major component of the CNS, there is little information on how or whether a change in sterol flux across the blood-brain barrier might alter neurodegeneration. In Niemann-Pick type C (NPC) disease, a mutation in NPC1 protein causes unesterified cholesterol to accumulate in the lysosomal compartment of every cell, including neurons and glia. Using the murine model of this disease, we used genetic and pharmacologic approaches in an attempt to alter cholesterol homeostasis across the CNS. Genetic deletion of the sterol transporters ATP-binding cassette transporter A1 (ABCA1) and low-density lipoprotein receptor in the NPC1 mouse did not affect sterol balance or longevity. However, deletion of the nuclear receptor, liver X receptor beta (LXRbeta), had an adverse effect on progression of the disease. We therefore tested the effects of increasing LXR activity by oral administration of a synthetic ligand for this transcription factor. Treatment with this LXR agonist increased cholesterol excretion out of brain from 17 to 49 microg per day, slowed neurodegeneration, and prolonged life. This agonist did not alter synthesis of cholesterol or expression of genes associated with the formation of 24(S)-hydroxycholesterol or neurosteroids such as CYP46A1, 3alphaHSD, and CYP11A1. However, levels of the sterol transporters ABCA1 and ATP-binding cassette transporter G1 were increased. Concomitantly, markers of neuroinflammation, CD14, MAC1, CD11c, and inducible nitric oxide synthase, were reduced, and microglia reverted from their amoeboid, active form to a ramified, resting configuration. Thus, LXR activation resulted in increased cholesterol excretion from the brain, decreased neuroinflammation, and deactivation of microglia to slow neurodegeneration and extend the lifespan of the NPC1 mouse.
Asunto(s)
Encéfalo/metabolismo , Colesterol/sangre , Proteínas de Unión al ADN/fisiología , Enfermedades Neurodegenerativas/dietoterapia , Enfermedades de Niemann-Pick , Proteínas/genética , Receptores Citoplasmáticos y Nucleares/fisiología , Transportadoras de Casetes de Unión a ATP/genética , Transportadoras de Casetes de Unión a ATP/metabolismo , Factores de Edad , Análisis de Varianza , Animales , Apoptosis/genética , Encéfalo/patología , Colesterol/administración & dosificación , Proteínas de Unión al ADN/deficiencia , Modelos Animales de Enfermedad , Péptidos y Proteínas de Señalización Intracelular , Metabolismo de los Lípidos , Receptores X del Hígado , Ratones , Ratones Endogámicos BALB C , Ratones Noqueados , Modelos Biológicos , Proteínas del Tejido Nervioso/metabolismo , Enfermedades Neurodegenerativas/etiología , Neuroglía/metabolismo , Neuroglía/patología , Neuronas/metabolismo , Neuronas/patología , Proteína Niemann-Pick C1 , Enfermedades de Niemann-Pick/dietoterapia , Enfermedades de Niemann-Pick/genética , Enfermedades de Niemann-Pick/mortalidad , Enfermedades de Niemann-Pick/patología , Receptores Nucleares Huérfanos , Receptores Citoplasmáticos y Nucleares/deficiencia , Receptores Citoplasmáticos y Nucleares/metabolismoRESUMEN
A multi-approach study in a series of 25 Czech and Slovak patients with acid sphingomyelinase deficiency revealed a broad phenotypic variability within Niemann-Pick disease types A and B. The clinical manifestation of only 9 patients fulfilled the historical classification: 5 with the rapidly progressive neurovisceral infantile type A and 4 with a slowly progressive visceral type B. Sixteen patients (64%) represented a hitherto scarcely documented 'intermediate type' (IT). Twelve patients showed a protracted neurovisceral course with overt or mild neurological symptoms, three a rapidly progressing fatal visceral affection with rudimentary neurological lesion. One patient died early from a severe visceral disease. The genotype in our patients was represented by 4 frameshift and 14 missense mutations. Six were novel (G166R, R228H, A241V, D251E, D278A, A595fsX601). The Q292K mutation (homoallelic, heteroallelic) was strongly associated with a protracted neurovisceral phenotype (10 of 12 cases). The sphingomyelin loading test in living fibroblasts resulted in total degradation from less than 2% in classical type A to 70-80% in classical type B. In the IT group it ranged from 5% to 49% in a 24 h chase. The liver storage showed three patterns: diffuse, zonal (centrolobular), and discrete submicroscopic. Our series showed a notable variability in both the neurological and visceral lesions as well as in their proportionality and synchrony, and demonstrates a continuum between the historical 'A' and 'B' phenotypes of ASM deficiency. This points to a broad phenotypic potential of ASM deficiency, suggesting the existence of still unknown factors independently controlling the storage level in the visceral and neuronal compartments. This report highlights the important position of the IT in the ASM deficiency phenotype classification. We define IT as a cluster of variants combining clinical features of both the classical types. The protracted neuronopathic variant with overt, borderline or subclinical neurology prevails and is important in view of future enzyme replacement therapy. It appears more common in central Europe. The visceral, rapidly progressing early fatal type has been recognized rarely so far.
Asunto(s)
Enfermedades de Niemann-Pick/genética , Enfermedades de Niemann-Pick/fisiopatología , Esfingomielina Fosfodiesterasa/genética , Adolescente , Adulto , Línea Celular Transformada , Niño , Preescolar , República Checa/epidemiología , Femenino , Fibroblastos/citología , Fibroblastos/fisiología , Mutación del Sistema de Lectura , Genotipo , Humanos , Hidrólisis , Lactante , Hígado/metabolismo , Masculino , Mutagénesis Sitio-Dirigida , Mutación Missense , Enfermedades de Niemann-Pick/mortalidad , Fenotipo , Polimorfismo de Longitud del Fragmento de Restricción , Prevalencia , Índice de Severidad de la Enfermedad , Piel/citología , Eslovaquia/epidemiología , Esfingomielina Fosfodiesterasa/metabolismoRESUMEN
Niemann-Pick disease (NPD) results from the deficiency of lysosomal acid sphingomyelinase (SMPD1). To date, out of more than 70-disease associated alleles only a few of them have a significant frequency in various ethnic groups. In contrast, the remainder of the mutations are rare or private. In this paper we report the molecular characterization of an Italian series consisting of twenty-five NPD patients with the severe neurodegenerative A phenotype. Mutation detection identified a total of nineteen different mutations, including 14 novel mutations and five previously reported lesions. The known p.P189fs and the novel p.T542fs were the most frequent mutations accounting for 34% and 18% of the alleles, respectively. Screening the alleles for the three common polymorphisms revealed the variant c.1516G>A (exon 6) and the repeat in exon 1, but not the variant c.965C>T (exon 2). In absence of frequent mutations, the prognostic value of genotyping is limited. However, new genotype/phenotype correlations were observed for this disorder that could in the future facilitate genetic counseling and guide selection of patients for therapy.
Asunto(s)
Pruebas Genéticas/métodos , Mutación/genética , Enfermedades de Niemann-Pick/genética , Esfingomielina Fosfodiesterasa/genética , Alelos , Preescolar , Análisis Mutacional de ADN/métodos , Exones/genética , Fibroblastos/enzimología , Frecuencia de los Genes/genética , Genotipo , Humanos , Italia , Linfocitos/enzimología , Enfermedades de Niemann-Pick/enzimología , Enfermedades de Niemann-Pick/mortalidad , Esfingomielina Fosfodiesterasa/deficienciaRESUMEN
In Niemann-Pick disease type C (NPC), a genetic heterogeneity with two complementation groups--NPC1, comprising > or =95% of the families, and NPC2--has been demonstrated. Mutations in the NPC1 gene have now been well characterized. HE1 was recently identified as the gene underlying the very rare NPC2. Here we report the first comprehensive study of eight unrelated families with NPC2, originating from France, Algeria, Italy, Germany, the Czech Republic, and Turkey. These cases represent essentially all patients with NPC2 who have been reported in the literature, as well as those known to us. All 16 mutant alleles were identified, but only five different mutations, all with a severe impact on the protein, were found; these five mutations were as follows: two nonsense mutations (E20X and E118X), a 1-bp deletion (27delG), a splice mutation (IVS2+5G-->A), and a missense mutation (S67P) resulting in reduced amounts of abnormal HE1 protein. E20X, with an overall allele frequency of 56%, was established as the common mutant allele. Prenatal diagnosis was achieved by mutation analysis of an uncultured chorionic-villus sample. All mutations except 27delG were observed in a homozygous state, allowing genotype/phenotype correlations. In seven families (with E20X, E118X, S67P, and E20X/27delG mutations), patients suffered a severe and rapid disease course, with age at death being 6 mo-4 years. A remarkable feature was the pronounced lung involvement, leading, in six patients, to early death caused by respiratory failure. Two patients also developed a severe neurological disease with onset during infancy. Conversely, the splice mutation corresponded to a very different clinical presentation, with juvenile onset of neurological symptoms and prolonged survival. This mutation generated multiple transcripts, including a minute proportion of normally spliced RNA, which may explain the milder phenotype.
Asunto(s)
Proteínas Portadoras , Glicoproteínas/genética , Mutación/genética , Enfermedades de Niemann-Pick/genética , Enfermedades de Niemann-Pick/fisiopatología , Adulto , Edad de Inicio , Western Blotting , Preescolar , Codón sin Sentido/genética , Análisis Mutacional de ADN , Exones/genética , Femenino , Fibroblastos , Frecuencia de los Genes/genética , Genotipo , Humanos , Lactante , Pulmón/fisiopatología , Masculino , Datos de Secuencia Molecular , Mutación Missense/genética , Enfermedades de Niemann-Pick/diagnóstico , Enfermedades de Niemann-Pick/mortalidad , Fenotipo , Diagnóstico Prenatal , Mapeo Restrictivo , Eliminación de Secuencia/genética , Proteínas de Transporte VesicularRESUMEN
The primary molecular defect underlying Niemann-Pick C disease (NPC) is still unknown. A wide spectrum of clinical and biochemical phenotypes has previously been documented. Indication of genetic heterogeneity has recently been provided for one patient. In the present study, somatic cell hybridization experiments were carried out on skin fibroblast cultures from 32 unrelated NPC patients covering the range of known clinical and biochemical phenotypes. The criterion for complementation was the restoration of a normal intracellular fluorescent pattern in polykaryons stained with filipin to document cholesterol distribution. Crosses between the various cell lines revealed a major complementation group comprising 27 unrelated patients and a second minor group comprising 5 patients. Linkage analysis in one multiplex family belonging to the minor complementation group showed that the mutated gene does not map to the 18q11-12 region assigned to the major gene. Patients in the first group spanned the whole spectrum of clinical and cellular phenotypes. No consistent clinical or biochemical phenotypes was associated with the second complementation group. Three of the five group 2 patients, however, presented with a new rare phenotype associated with severe pulmonary involvement leading to death within the first year of life. No biochemical abnormality specific of either group could be demonstrated with regard to tissue lipid storage pattern, intralysosomal cholesterol storage, and regulation of cholesterol homeostasis. Mutations affecting at least two different genes have thus been shown to underlie NPC. The two gene products may function together or sequentially in a common metabolic pathway affecting intracellular cholesterol transport.
Asunto(s)
Cromosomas Humanos Par 18 , Enfermedades de Niemann-Pick/genética , Adolescente , Adulto , Factores de Edad , Células Cultivadas , Niño , Preescolar , Colesterol/metabolismo , Mapeo Cromosómico , Femenino , Feto , Fibroblastos/metabolismo , Filipina , Prueba de Complementación Genética , Ligamiento Genético , Humanos , Células Híbridas , Lactante , Hígado/metabolismo , Enfermedades de Niemann-Pick/mortalidad , Fenotipo , Fosfolípidos/metabolismo , Reacción en Cadena de la Polimerasa , Embarazo , Piel/metabolismo , Esfingomielinas/metabolismo , Bazo/metabolismoRESUMEN
The records of 52 children with Niemann-Pick disease type C were reviewed to establish whether the disease process and outcome varied with the initial clinical pattern; 34 children (65%) had cholestatic liver disease and hepatosplenomegaly in infancy; 18 were seen at a mean age of 4 years with splenomegaly or neurologic disease or both. Of the 34 children with early cholestatic liver disease, three died in the neonatal period; cholestasis and hepatomegaly subsided in the remaining 31 children, although splenomegaly persisted. Of these 31 children, 15 had persistent liver disease with elevated aminotransferase values. Serial liver biopsy specimens showed that 3 of the 15 children had normal architecture and 12 had hepatic fibrosis, with progression to cirrhosis in 5. No other significant morbidity or additional deaths were associated with the liver disease. The clinical importance of persistent liver disease was overshadowed by the subsequent development of severe neurologic disease. There was no difference in the age at onset of the disease (mean, 4.5 years) or in the pattern of neurologic disease, including supranuclear ophthalmoplegia, whether or not the child had early liver disease. Overt neurologic disease has not yet developed in seven surviving children with liver disease at onset. Sixty-seven percent of children died during the study; the main cause of death was bronchopneumonia. We conclude that the diagnosis of Niemann-Pick disease type C should be considered in patients with unexplained neonatal hepatitis, especially if splenomegaly is a persistent feature. Because liver biopsy specimens may not demonstrate storage cells, bone marrow aspiration to detect the characteristic storage cells is recommended in such patients.
Asunto(s)
Hepatopatías/diagnóstico , Hígado/patología , Enfermedades de Niemann-Pick/diagnóstico , Factores de Edad , Biopsia , Niño , Preescolar , Discapacidades del Desarrollo/etiología , Femenino , Humanos , Lactante , Macrófagos del Hígado/patología , Hepatopatías/etiología , Hepatopatías/mortalidad , Pruebas de Función Hepática , Masculino , Enfermedades de Niemann-Pick/complicaciones , Enfermedades de Niemann-Pick/mortalidad , Pronóstico , Estudios Retrospectivos , Esplenomegalia/etiologíaRESUMEN
Se hace una revisión de la enfermedad de Niemann-Pick que es una alteración innata del metabolismo de los fosfolípidos, la ESPINGOMIELINA, que se acumula en los lisosomas, constituyendo la enfermedad lisosomal, debido a una alteración cualitativa o cuantitativa de la ESZPINGOMIELINASA. La enfermedad es transmitida en forma autosómica recesiva, alterando los diversos órganos, especialmente el sistema nervioso y el fondo de ojo en el cual se observa en la mácula una mancha de color cereza. A continuación se presenta el caso problema en un indígena puro del Cañar-Ecuador (años anteriores se encontró otro caso que fue descrito por su extrema rareza), existe consanguinidad; hepatoesplenomegalia, mancha roja en mácula y células espúmosas en médula ósea. Un hermano falleció con identicas características clínicas.
Asunto(s)
Humanos , Masculino , Lactante , Errores Innatos del Metabolismo/fisiopatología , Enfermedades de Niemann-Pick/metabolismo , Técnicas de Laboratorio Clínico , Enfermedades de Niemann-Pick/dietoterapia , Enfermedades de Niemann-Pick/mortalidad , Enfermedades de Niemann-Pick/fisiopatología , Fosfolípidos , EsfingomielinasRESUMEN
Analysis of the temporal sequence of neurologic events, neurophysiologic abnormalities, and longevity in 36 Niemann-Pick type C patients revealed two clinical subgroups with five stages of severity within each group. Patients with a preschool onset (group I; n = 18) had a higher mortality than did patients with a school-age onset (group II; n = 18). An asymptomatic phase (stage 0) was defined by biochemical and histopathologic evidence of disease. The initial manifestations of stage 1 were a movement disorder (group I) and cognitive difficulties (group II) accompanied by impaired vertical saccadic eye movements and abnormal acoustic reflexes. Stage 2 was characterized by the sequential occurrence of vertical supranuclear gaze palsy (VSGP), cognitive difficulties, and dysarthria in group I and a movement disorder, VSGP, and dysarthria in group II. Pyramidal tract signs and abnormal brainstem auditory evoked responses defined stage 3 in both groups. Stage 4 culminated in a nonambulant, vegetative state.